PubMed · 8923590
Systemic sclerosis. A vascular perspective.
Abstract
The horizon is bright for SSc in a vascular context. Surrogate markers can now be routinely used in the management of the active patient; new cytokines, such as VEGF, can be studied along with the known abnormalities of the cytokine cascade (TGF beta 1, PDGF) for a more integrated understanding of the vascular pathogenesis of SSc (Fig. 6); and combination therapies can be applied before vascular insufficiency leads to vital organ failure. Thus, despite reimbursement and research funding constraints, the future for both the SSc patient and the investigator of SSc is optimistic when based on a firm biologic foundation.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
E C LeRoy. 1996. Systemic sclerosis. A vascular perspective.. https://doi.org/10.1016/s0889-857x(05)70295-7. https://searchpubmed.org/record/pubmed%3A8923590/systemic-sclerosis-a-vascular-perspective
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite Search PubMed by Indiciae: BibTeX · RIS.